Reference
Henning B, et al. Pyogenic granuloma in patients treated with selective BRAF inhibitors: Another manifestation of paradoxical pathway activation. Melanoma Research 26: 304-307, No. 3, Jun 2016. Available from: URL: http://doi.org/10.1097/CMR.0000000000000248 - Switzerland
Rights and permissions
About this article
Cite this article
Encorafenib/vemurafenib. Reactions Weekly 1606, 61 (2016). https://doi.org/10.1007/s40278-016-18465-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-18465-0